AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism
AARS2, an alanyl-tRNA synthase, is essential for protein translation, but its function in mouse hearts is not fully addressed. Here, we found that cardiomyocyte-specific deletion of mouse AARS2 exhibited evident cardiomyopathy with impaired cardiac function, notable cardiac fibrosis, and cardiomyocy...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2025-05-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/99670 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849322093004455936 |
|---|---|
| author | Zongwang Zhang Lixia Zheng Yang Chen Yuanyuan Chen Junjie Hou Chenglu Xiao Xiaojun Zhu Shi-Min Zhao Jing-Wei Xiong |
| author_facet | Zongwang Zhang Lixia Zheng Yang Chen Yuanyuan Chen Junjie Hou Chenglu Xiao Xiaojun Zhu Shi-Min Zhao Jing-Wei Xiong |
| author_sort | Zongwang Zhang |
| collection | DOAJ |
| description | AARS2, an alanyl-tRNA synthase, is essential for protein translation, but its function in mouse hearts is not fully addressed. Here, we found that cardiomyocyte-specific deletion of mouse AARS2 exhibited evident cardiomyopathy with impaired cardiac function, notable cardiac fibrosis, and cardiomyocyte apoptosis. Cardiomyocyte-specific AARS2 overexpression in mice improved cardiac function and reduced cardiac fibrosis after myocardial infarction (MI), without affecting cardiomyocyte proliferation and coronary angiogenesis. Mechanistically, AARS2 overexpression suppressed cardiomyocyte apoptosis and mitochondrial reactive oxide species production, and changed cellular metabolism from oxidative phosphorylation toward glycolysis in cardiomyocytes, thus leading to cardiomyocyte survival from ischemia and hypoxia stress. Ribo-Seq revealed that Aars2 overexpression increased pyruvate kinase M2 (PKM2) protein translation and the ratio of PKM2 dimers to tetramers that promote glycolysis. Additionally, PKM2 activator TEPP-46 reversed cardiomyocyte apoptosis and cardiac fibrosis caused by AARS2 deficiency. Thus, this study demonstrates that AARS2 plays an essential role in protecting cardiomyocytes from ischemic pressure via fine-tuning PKM2-mediated energy metabolism, and presents a novel cardiac protective AARS2-PKM2 signaling during the pathogenesis of MI. |
| format | Article |
| id | doaj-art-e3475e5c1caf46f789d672aed47fad91 |
| institution | Kabale University |
| issn | 2050-084X |
| language | English |
| publishDate | 2025-05-01 |
| publisher | eLife Sciences Publications Ltd |
| record_format | Article |
| series | eLife |
| spelling | doaj-art-e3475e5c1caf46f789d672aed47fad912025-08-20T03:49:32ZengeLife Sciences Publications LtdeLife2050-084X2025-05-011310.7554/eLife.99670AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolismZongwang Zhang0https://orcid.org/0009-0008-3711-0090Lixia Zheng1Yang Chen2https://orcid.org/0009-0006-2087-8875Yuanyuan Chen3Junjie Hou4Chenglu Xiao5Xiaojun Zhu6Shi-Min Zhao7Jing-Wei Xiong8https://orcid.org/0000-0001-8438-4782Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Academy for Advanced Interdisciplinary Studies, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, ChinaBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Academy for Advanced Interdisciplinary Studies, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, ChinaBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Academy for Advanced Interdisciplinary Studies, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, ChinaBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Academy for Advanced Interdisciplinary Studies, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, ChinaSchool of Basic Medical Sciences and The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaSchool of Basic Medical Sciences and The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Academy for Advanced Interdisciplinary Studies, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, ChinaObstetrics and Gynecology Hospital of Fudan University, State Key Lab of Genetic Engineering, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Academy for Advanced Interdisciplinary Studies, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China; School of Basic Medical Sciences and The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaAARS2, an alanyl-tRNA synthase, is essential for protein translation, but its function in mouse hearts is not fully addressed. Here, we found that cardiomyocyte-specific deletion of mouse AARS2 exhibited evident cardiomyopathy with impaired cardiac function, notable cardiac fibrosis, and cardiomyocyte apoptosis. Cardiomyocyte-specific AARS2 overexpression in mice improved cardiac function and reduced cardiac fibrosis after myocardial infarction (MI), without affecting cardiomyocyte proliferation and coronary angiogenesis. Mechanistically, AARS2 overexpression suppressed cardiomyocyte apoptosis and mitochondrial reactive oxide species production, and changed cellular metabolism from oxidative phosphorylation toward glycolysis in cardiomyocytes, thus leading to cardiomyocyte survival from ischemia and hypoxia stress. Ribo-Seq revealed that Aars2 overexpression increased pyruvate kinase M2 (PKM2) protein translation and the ratio of PKM2 dimers to tetramers that promote glycolysis. Additionally, PKM2 activator TEPP-46 reversed cardiomyocyte apoptosis and cardiac fibrosis caused by AARS2 deficiency. Thus, this study demonstrates that AARS2 plays an essential role in protecting cardiomyocytes from ischemic pressure via fine-tuning PKM2-mediated energy metabolism, and presents a novel cardiac protective AARS2-PKM2 signaling during the pathogenesis of MI.https://elifesciences.org/articles/99670AARS2PKM2cardiomyocytesglycolysiscardiac remodeling |
| spellingShingle | Zongwang Zhang Lixia Zheng Yang Chen Yuanyuan Chen Junjie Hou Chenglu Xiao Xiaojun Zhu Shi-Min Zhao Jing-Wei Xiong AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism eLife AARS2 PKM2 cardiomyocytes glycolysis cardiac remodeling |
| title | AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism |
| title_full | AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism |
| title_fullStr | AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism |
| title_full_unstemmed | AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism |
| title_short | AARS2 ameliorates myocardial ischemia via fine-tuning PKM2-mediated metabolism |
| title_sort | aars2 ameliorates myocardial ischemia via fine tuning pkm2 mediated metabolism |
| topic | AARS2 PKM2 cardiomyocytes glycolysis cardiac remodeling |
| url | https://elifesciences.org/articles/99670 |
| work_keys_str_mv | AT zongwangzhang aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT lixiazheng aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT yangchen aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT yuanyuanchen aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT junjiehou aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT chengluxiao aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT xiaojunzhu aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT shiminzhao aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism AT jingweixiong aars2amelioratesmyocardialischemiaviafinetuningpkm2mediatedmetabolism |